bluebird bio controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2019
Criticism of Zynteglo pricing
Zynteglo attracted criticism because its reported $1.8 million price placed it among the world's most expensive medicines, intensifying debate about access to one-time gene therapies and the allocation of payment over time.